Table 2.

Discharge or tracheostomy before discharge.

Comorbidities	Death prior to dc + trach outcome OR [95% CI; p value]	Death prior to dc outcome OR [95% CI; p value]	Trach outcome OR [95% CI; p value]
PHTN	13.58 [3.02, 61.14]; 0.0007	8.59 [3.37, 21.89]; <0.0001	1.80 [1.07,3.01]; 0.0264
Cardiac	0.84 [0.30, 2.32]; 0.7330	1.36 [0.61, 3.04]; 0.4507	0.89 [0.54, 1.46]; 0.6375
Neuro	0.60 [0.20, 1.78]; 0.3596	0.65 [0.29, 1.45]; 0.2931	1.27 [0.78, 2.09]; 0.3381
Genetic	1.67 [0.55, 4.98]; 0.3671	1.92 [0.84, 4.36]; 0.1202	1.09 [0.61, 1.96]; 0.7722
Ophthalmic	0.52 [0.19, 1.45]; 0.2137	0.58 [0.27, 1.23]; 0.1554	0.80 [0.49,1.31]; 0.3714
Infection	0.55 [0.05, 6.59]; 0.6396	2.17 [0.24, 19.28]; 0.4881	2.04 [0.56, 7.39]; 0.2795
BPD	1.89 [0.52,6.84]; 0.3301	1.18 [0.50, 2.78]; 0.6998	0.85 [0.49, 1.45]; 0.5387
GI	0.66 [0.22, 1.97]; 0.4602	0.72 [0.32,1.61]; 0.4255	1.24 [0.75, 2.03]; 0.4067
G tube	7.28 [0.95, 56.01]; 0.0567	0.40 [0.19, 0.69]; 0.023	9.28 [5.06, 17.04]; <0.0001
Fundo	0.91 [0.20, 4.19]; 0.9055	0.43 [0.10, 1.87]; 0.2591	1.80 [0.84,3.82]; 0.1283

Logistic regression analysis was completed for ten different comorbidities for outcomes included: death or tracheostomy prior to discharge, and combined outcome of death and tracheostomy prior to discharge. Pulmonary hypertension was associated with the odds of all three outcomes assessed.

dc discharge, PHTN pulmonary hypertension, trach tracheostomy, G tube gastrostomy tube, fundo fundoplication.